Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Overview on GTN in YGH (309P)


18 Nov 2017


Poster lunch


SAN Myint


Annals of Oncology (2017) 28 (suppl_10): x86-x93. 10.1093/annonc/mdx663


S.Y. Myint, P. Phyu Theint, S.S. Win, Z. Thynn, H.H. Maw

Author affiliations

  • Medical Oncology, University of Medicine I, 11131 - Yangon/MM



Gestational trophoblastic neoplasia (GTN) is a curable malignancy among female cancers and is quite common in our country. Occurrence is increasing and the disease course seems more aggressive. So we aimed to review our care and status of GTN in patients who attend to Yangon General Hospital (YGH).


This summary descriptive study was undertaken in the Medical Oncology Department of YGH, the main tertiary centre in Myanmar. Cases were collected from October 2015 to September 2016. Data analysis was done by age, risk score, βhCG level, sites of metastasis, surgeries received, types of regimes and numbers of cycles, response and outcomes up to June 2017


Among the total of 58 patients the youngest was 17 and the oldest was 51, mean age was 33, βhCG level were above 100,000 in 33 (56.6%) and below in 25 (43.1%). Most common metastasis site was lung 13 (22.4%), brain 3(5.1%). Bladder invasions were seen in 4 (6.8%). 11 patients (18.9%) showed low risk score and 47 (81%) had high risk score. 52 patients (89%) had diagnosis by suction curettage and 6 patients (10.3%) had total hysterectomy due to uncontrolled bleeding. Single agent chemotherapy was given to 14 (24.1%) and EMA CO regime to 44 (75%), later change from single agent to EMA CO were 4 (6.8%) and from EMA CO to EMA CE were 5 (8.6%). Total cycles of chemotherapy for complete remission were more than 6 cycles for 20 (34.4%). 21 patients (36%) did not complete treatment and 4 patients (6.8%) expired during treatment due to severe late stage disease complications. Complete remission was seen in 33 (58%) with regular follow up. Grade 3 hematological toxicity (neutropenia) was seen in most of the cases but was manageable. Radiotherapy was given to the brain metastasis.


Since, our hospital is a tertiary centre serious cases were referred to us. Most of the patients showed complete remission except those who did not complete treatment, which may be due to socioeconomic problems. Strategies to develop resources, better clinical documentation and proper referral systems need to improve.

Clinical trial identification

Legal entity responsible for the study

University of Medicine 1




All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings